SCHEMBL7675029

SCHEMBL7675029

CCCCC(NC(=O)c1ccccc1Oc1ccccc1)C(=O)CNS(=O)(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CASP1 P29466 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ADAMTS4 O75173 2/20 0.42
MMP1 P03956 2/20 0.42
MMP2 P08253 2/20 0.42
MMP13 P45452 2/20 0.42
MMP14 P50281 2/20 0.42
ADAMTS5 Q9UNA0 2/20 0.42
MEP1B Q16820 1/20 0.42
MAPT P10636 2/20 0.41
POLB P06746 2/20 0.41
LMNA P02545 1/20 0.41
ICMT O60725 1/20 0.41
C3AR1 Q16581 1/20 0.41
RAB9A P51151 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CA2 P00918 1/20 0.40
BCL2L1 Q07817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7421842 0.90 L3MBTL1 (0.46) L3MBTL1NPSR1KDM4EMAPTPOLB
SCHEMBL7701291 0.89 GFER (0.41) L3MBTL1CASP1KDM4EADAMTS4MMP1
SCHEMBL7701336 0.86 CASP1 (0.49) L3MBTL1NPSR1CASP1KDM4EADAMTS4
SCHEMBL7428250 0.85 KCNA5 (0.44) CASP1MMP1MMP2MMP13MMP14
SCHEMBL7659831 0.83 KDM4E (0.48) L3MBTL1NPSR1KDM4EMAPTPOLB
SCHEMBL7564537 0.83 CA2 (0.54) NPSR1CASP1MMP1LMNARAB9A
SCHEMBL7666903 0.82 KDM4E (0.47) L3MBTL1NPSR1KDM4EMAPTPOLB
SCHEMBL7695233 0.80 CAPN1 (0.54) CASP1MMP1MMP2MMP13MMP14
SCHEMBL7422050 0.79 KCNA5 (0.49) KDM4EMMP1MMP13HSD17B10MEN1
SCHEMBL7606033 0.78 CASP1 (0.37) CASP1ADAMTS4MMP1MMP2MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed